Vision
Value
Visibility
Report Code : HC1005
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis
+1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422, +91-844-785-9968 sales@goldsteinresearch.com
99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America Office No:- 504, 5th Floor, C51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India
www.goldsteinresearch.com
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis Global Injectable Drugs Market Outlook Drugs which are introduced into body with syringe & needle as a medium is termed as injectable drugs. Among all the approved drugs by Food & Drug Administration (FDA) available in U.S., 97% of medications & vaccines are administered through injections. Top injectable drugs such as remicade, avastin neulasta, rituxan, etc. are most commonly used across the globe. In 2012, over 180,000 units of remicade were available per one million lives worldwide. Nowadays, increasing price of injectable biotech products is a challenge for every commercial player in the United Sates. In 2010, approval of several cancer therapies by FDA has driven the cost of injectable drugs up to 4.0%. However, injectable drugs used for cancer treatment accounted for more than 50.0% of benefits of medical injectable costs. Recent increase in commercial health plans is establishing attractive business opportunities for injectable drugs in Europe and North America region. In 2012, more than 60% of population in the United States received medical benefits, which is extensively raising the demand of injectable drugs in the region. Although, illegal use of injectable drugs is expected to hamper the adoption rate of injectable drugs across the globe. In 2012, Greece and the UK have 3.1% and nearly 10% of per 1000 population who were using injectable drugs illegally. Spain, UK, France and Italy has higher rate of abusing medical drugs as compared to other European countries. Moreover, the U.S. and Canada have nearly 3.0% of population aged above 12 years are illegally using medical injectable drugs. This is one of the major factors which are obstructing the injectable drugs market. However, stringent drugs polices is likely to reduce the illegitimate use of injectable drugs worldwide. Acquisition and collaboration plays an important role in enabling business opportunities for injectable drugs. For instance, In July 2016, Lupin pharmaceutical acquired two medical companies of New Jersey worth USD 900 million. In the same year, InvaGen Pharmaceutical was acquired by Cipla for USD 550 million. In October 2016, India based company Piramal announced to buy 5 drugs for pain and anesthetic management from Johnson & Johnson by paying USD 155 million. Piramal holds a significant presence in global generic injectable drug market which valued USD 20 billion in 2016. These acquisitions and partnerships are expected to drive the growth of injectable drugs market during the time period of 2016-2024.
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis Market Segmentation Sample Request Based on Product Type •
Vaccines
•
Insulin
•
Conventional Therapeutics
•
Complex Biologics
Send Us Sample Request@ https://www.goldsteinresearch.com/request-sample/globalinjectable-drugs-market-outlook-2024-global-opportunity-and-demand-analysis-marketforecast-2016-2024
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis
Based on Geography North America (US, Canada) {Market Share (%), Market Size (USD Million), Production (Units)} Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market
Share (%), Market Size (USD Million), Production (Units)} Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Million), Production (Units) } Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Million) , Production (Units)} Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Million), Production (Units)} Rest of the World {Market Share (%), Market Size (USD Million), Production (Units)}
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis Market Size and Forecast (2016-2024) Global injectable drugs market is anticipated to reach USD 513.5 billion by 2024 from value USD 272.7 billion in 2016, growing at a CAGR of 8.23% during the forecast period of 2016 to 2024. North America is the dominating region in global injectable drugs market in 2016. Rising number of chronic health issues and increasing number of partnership between medical companies to provide high quality affordable drugs is boosting the demand of injectable drugs in U.S. and Canada. North America valued 109.1 billion in 2016 and is expected to reach USD 184.9 billion by 2024.
Based on segmentation, complex biologics holds the largest share nearly 60.0% of global injectable drugs market in 2016. Increase in number of new drugs rising demand for license approval for biologics and new drugs is accelerating the market of complex biologics segment. Vaccines and insulin segment is expected to witness notable growth with 20.0% and 10.0% share of injectable drugs market over the forecast period. Asia-Pacific region is expected to be the fastest growing region in injectable drug market over the forecast period. Asia-Pacific region is expected to reach the value of USD 133.5 billion by the end of 2024, growing at a CAGR of 10.51 % over the forecast period. Rising health awareness and growing penetration of self injection technology in Japan, Singapore & China is boosting the demand of injectable drugs in the region. Increasing number of diabetes population in emerging economies such as India & China is expected to witness significant growth during the time period of 2016-2024.
XX
Injectable Drugs Market Size (USD Billion), 2016-2024
Population using Injectable Drugs (%), By Disease
XX
XX
Respiratory disease
XX
XX%
XX
XX
Muscoskeletol disease
XX
XX%
XX XX
XX
XX%
Heart Disease
XX%
XX
XX XX
Injuries
XX
XX
XX
XX
XX
Circulatory disease
XX%
XX 2016e
2017e
2018f
2019f
2020f
2021f
2022f
2023f
2024f
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis Global Injectable Drugs Market Outlook 2024 contains detailed overview of the global injectable drugs market in terms of market segmentation by product type. Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Sacle) analysis, Porter’s five force model and SWOT analysis. Global Injectable Drugs Market Report also provides competitive outlook of some of the major players of the global injectable drugs market which includes profiling of companies Pfizer Inc., Johnson & Johnson, Novartis AG, Merck & Co. Inc., . The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents comprehensive synopsis on the global injectable drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request for TOC@ https://www.goldsteinresearch.com/toc-request/global-injectable-drugs-marketoutlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis Scope Background Market Synopsis
Sample Request
Market Segmentation The Injectable Drugs market Segmentation as follows: •
By Product Types (Market Size, Demand Analysis and Growth Analysis)
By Country
North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis} Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis} Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis} Asia-Pacific (China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis} Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis} Rest of World {Market Size, Growth Analysis and Opportunity Analysis}
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis Market Dynamics: Growth Drivers, Restraints and Opportunities oRisk Factors oRegional Variations oRecent Trends and Developments
Sample Request
Key Market Players oSynopsis oBusiness Strategy oProduct Portfolio oSWOT Analysis
Porter’s Five Force Model Market Landscape: Competition and Beyond Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem Expert Analysis Concluding Remarks
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis About Goldstein Research Based in U.S., Goldstein Research is a young business consulting and market research firm with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a
robust business model and strategies, which would add to your profitability and market visibility as a brand.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis
Sample Request
For more information Contact Us: +1-646-568-7747
99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America
+1-437-886-1181
+44-203-318-6627
Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India
+91-120-473-0422, +91-844-785-9968 sales@goldsteinresearch.com
www.goldsteinresearch.com
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Emerging Injectable Drugs Market Outlook 2016-2024 | Insights, Trends, Demand & Competitors Analysis
Thank you Thank you
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com